ELITE TEST
BANK: FAMILY
PRACTICE
GUIDELINES
(6TH ED) &
2026/2027
CLINICAL
STANDARDS
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Critical Action" Cheat Sheet
○ 2026/2027 Clinical Standards Crosswalk
● PART II: THE ELITE TEST BANK
○ Section 1: Foundational Syntax & Application (Questions 1–28): Testing the
"Hard Deck" definitions, Texas Board of Nursing regulations, and 2026 guideline
updates.
○ Section 2: Professional Simulation (Questions 29–58): Immediate clinical triage,
, acute exacerbation management, and localized prescriptive execution.
○ Section 3: Grandmaster Synthesis (Questions 59–88): Multi-system crisis
management, HCC V28 documentation, polypharmacy, and advanced professional
identity formulation.
PART I: THE PRIMER
Welcome to the pinnacle of advanced clinical preparation. This Elite Test Bank is engineered to
intercept high-stakes professional errors before they reach a live patient. Utilizing the Family
Practice Guidelines 6th Edition as our foundational architecture, this document bridges the gap
between academic theory and the raw, unyielding reality of 2026/2027 top-tier professional
practice. You will not find rote memorization here; you will find the crucible of clinical judgment.
The "Critical Action" Cheat Sheet:
● The T.A.P.E. Doctrine: Teaching, Assessment, Planning, and Evaluation are the
exclusive domain of the licensed practitioner and can never be delegated to Unlicensed
Assistive Personnel (UAP).
● Texas BON Retention Mandate: Advanced Practice Registered Nurses (APRNs) must
retain a copy of their Prescriptive Authority Agreement (PAA) for exactly two years
following its termination.
● AHA 2026 Stroke Protocol: Tenecteplase is the preferred thrombolytic agent; it must be
administered within a strict 4.5-hour window from symptom onset.
● GOLD 2026 Exacerbation Rule: A single moderate chronic obstructive pulmonary
disease (COPD) exacerbation immediately classifies a patient into Group E, demanding
proactive therapeutic escalation.
● ADA 2026 Glycemic Targets: Maintain non-critically ill hospitalized clients between
100–180 mg/dL; critically ill clients demand a strict 140–180 mg/dL maintenance buffer.
2026/2027 Clinical Standards Crosswalk
Domain 2026/2027 Standard Clinical Implication Source
Update
Pulmonology GOLD: High Flow HFNT is now a first-line
Nasal Therapy (HFNT) respiratory support
choice for persistent
hypoxemia in COPD
exacerbations,
bypassing early
intubation.
Nephrology KDIGO: Anemia in Erythropoiesis-stimulati
CKD ng agents (ESAs)
remain the preferred
first-line therapy,
utilizing proactive
intravenous (IV) iron
supplementation.
Endocrinology ADA: Weight Intentional weight loss
Management protocols strictly target
a 5-7% baseline
reduction, with
,Domain 2026/2027 Standard Clinical Implication Source
Update
mandatory screening
for protein insufficiency.
Documentation CMS: HCC V28 Over 2,000 legacy
Transition ICD-10 codes (V24) are
eliminated. High
specificity (e.g., Asthma
mapped independently)
is mandatory for acuity
scoring.
Ethics/Law Texas BON: AI in The practitioner bears
Nursing (15.31) ultimate,
non-transferable liability
for verifying any data or
documentation
generated by ambient
AI scribes.
PART II: THE ELITE TEST BANK
Section 1: Foundational Syntax & Application
Q1: Under the 2026 Texas Board of Nursing regulations, an APRN’s prescriptive authority
agreement with a collaborating physician terminates on May 1, 2025. What is the LATEST date
the APRN is legally mandated to retain a copy of this agreement? A) May 1, 2026 B) May 1,
2027 C) December 31, 2027 D) Indefinitely, as part of the permanent professional record.
● The Answer: B (May 1, 2027)
● Distractor Analysis:
○ A is incorrect: One year is insufficient and violates Board Rule 222.5(h).
○ C is incorrect: Record retention is based on the exact anniversary date, not the
calendar year-end.
○ D is incorrect: Indefinite retention is a bureaucratic myth; the legal standard is
exactly two years.
The Mentor's Analysis: Regulatory compliance is absolute. Texas is not a full-practice
authority state; your ability to practice hinges on your collaborative paperwork. The Board
demands a two-year retention period to ensure audit trails remain intact during biennial license
renewals. Professional Intuition: Your license is your livelihood. Never discard legal
documentation before the statutory expiration.
Q2: According to the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD)
report, a patient presents with a history of a single moderate exacerbation in the past 12
months. Which category BEST classifies this patient's disease activity? A) Group A B) Group B
C) Group C D) Group E
● The Answer: D (Group E)
● Distractor Analysis:
○ A & B are incorrect: These groups represent patients with zero or one
non-hospitalized exacerbation without moderate/severe features under legacy
guidelines.
, ○ C is incorrect: Group C and D were consolidated into Group E in recent updates to
simplify exacerbation risk.
○ D is correct: The 2026 guidelines lower the threshold; a single exacerbation
meaningfully increases the probability of recurrent events, placing them in Group E.
The Mentor's Analysis: The 2026 GOLD update radically shifted risk assessment. We no
longer wait for a second exacerbation to escalate care. A single moderate exacerbation proves
the disease is biologically unstable. Professional Intuition: One strike means the patient is at
high risk for recurrence. Escalate immediately.
Q3: Under the 2026/2027 KDIGO clinical practice guidelines for Anemia in Chronic Kidney
Disease (CKD), which intervention is designated as the PREFERRED FIRST-LINE therapy? A)
Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) B) Routine red blood cell
transfusions C) Erythropoiesis-stimulating agents (ESAs) D) High-dose oral iron
supplementation
● The Answer: C (Erythropoiesis-stimulating agents (ESAs))
● Distractor Analysis:
○ A is incorrect: While HIF-PHIs are newly incorporated into the 2026 guidelines,
ESAs remain the preferred first-line due to established cardiovascular safety
profiles.
○ B is incorrect: Transfusions are a last resort due to alloimmunization risks,
especially in potential transplant candidates.
○ D is incorrect: Proactive IV iron, not oral, is emphasized for hemodialysis patients.
The Mentor's Analysis: Novel therapies like HIF-PHIs are exciting, but standard-of-care relies
on vast, longitudinal safety data. ESAs remain the vanguard for CKD anemia. Professional
Intuition: Do not abandon proven first-line therapies for novel agents unless specifically
indicated by patient contraindications.
Q4: The CMS Hierarchical Condition Categories (HCC) V28 model is fully implemented for the
2026 payment year. A practitioner is documenting care for a patient with diabetes. To ensure
accurate risk adjustment, the documentation must SPECIFICALLY capture which of the
following? A) The patient's exact A1C percentage from the last 30 days. B) The presence of
diabetes with explicit systemic or glycemic complications. C) A referral to a certified diabetes
educator. D) The legacy V24 code for "Diabetes without Complication."
● The Answer: B (The presence of diabetes with explicit systemic or glycemic
complications.)
● Distractor Analysis:
○ A & C are incorrect: While clinically relevant, lab values and referrals alone do not
drive HCC V28 risk capture; the specific diagnostic nomenclature does.
○ D is incorrect: V28 eliminates over 2,000 legacy codes. "Diabetes without
Complication" (HCC 19) transitions to a highly specific V28 code (HCC 38) requiring
explicit complication documentation.
The Mentor's Analysis: If it is not documented accurately under V28, the acuity of your patient
population is invisible to CMS. V28 demands hyper-granularity. Professional Intuition: Code
the whole patient. A complication changes the entire financial and clinical trajectory of the care
plan.
Q5: Per the 2026 American Diabetes Association (ADA) Standards of Care, a patient with Type
2 Diabetes is initiating a lifestyle management plan. What is the TARGET weight loss
percentage recommended to significantly alter the disease trajectory? A) 2-3% B) 5-7% C)
10-15% D) 20%
● The Answer: B (5-7%)
BANK: FAMILY
PRACTICE
GUIDELINES
(6TH ED) &
2026/2027
CLINICAL
STANDARDS
PART 0: THE NAVIGATOR
● PART I: THE PRIMER
○ The "Welcome to the Big Leagues" Hook
○ The "Critical Action" Cheat Sheet
○ 2026/2027 Clinical Standards Crosswalk
● PART II: THE ELITE TEST BANK
○ Section 1: Foundational Syntax & Application (Questions 1–28): Testing the
"Hard Deck" definitions, Texas Board of Nursing regulations, and 2026 guideline
updates.
○ Section 2: Professional Simulation (Questions 29–58): Immediate clinical triage,
, acute exacerbation management, and localized prescriptive execution.
○ Section 3: Grandmaster Synthesis (Questions 59–88): Multi-system crisis
management, HCC V28 documentation, polypharmacy, and advanced professional
identity formulation.
PART I: THE PRIMER
Welcome to the pinnacle of advanced clinical preparation. This Elite Test Bank is engineered to
intercept high-stakes professional errors before they reach a live patient. Utilizing the Family
Practice Guidelines 6th Edition as our foundational architecture, this document bridges the gap
between academic theory and the raw, unyielding reality of 2026/2027 top-tier professional
practice. You will not find rote memorization here; you will find the crucible of clinical judgment.
The "Critical Action" Cheat Sheet:
● The T.A.P.E. Doctrine: Teaching, Assessment, Planning, and Evaluation are the
exclusive domain of the licensed practitioner and can never be delegated to Unlicensed
Assistive Personnel (UAP).
● Texas BON Retention Mandate: Advanced Practice Registered Nurses (APRNs) must
retain a copy of their Prescriptive Authority Agreement (PAA) for exactly two years
following its termination.
● AHA 2026 Stroke Protocol: Tenecteplase is the preferred thrombolytic agent; it must be
administered within a strict 4.5-hour window from symptom onset.
● GOLD 2026 Exacerbation Rule: A single moderate chronic obstructive pulmonary
disease (COPD) exacerbation immediately classifies a patient into Group E, demanding
proactive therapeutic escalation.
● ADA 2026 Glycemic Targets: Maintain non-critically ill hospitalized clients between
100–180 mg/dL; critically ill clients demand a strict 140–180 mg/dL maintenance buffer.
2026/2027 Clinical Standards Crosswalk
Domain 2026/2027 Standard Clinical Implication Source
Update
Pulmonology GOLD: High Flow HFNT is now a first-line
Nasal Therapy (HFNT) respiratory support
choice for persistent
hypoxemia in COPD
exacerbations,
bypassing early
intubation.
Nephrology KDIGO: Anemia in Erythropoiesis-stimulati
CKD ng agents (ESAs)
remain the preferred
first-line therapy,
utilizing proactive
intravenous (IV) iron
supplementation.
Endocrinology ADA: Weight Intentional weight loss
Management protocols strictly target
a 5-7% baseline
reduction, with
,Domain 2026/2027 Standard Clinical Implication Source
Update
mandatory screening
for protein insufficiency.
Documentation CMS: HCC V28 Over 2,000 legacy
Transition ICD-10 codes (V24) are
eliminated. High
specificity (e.g., Asthma
mapped independently)
is mandatory for acuity
scoring.
Ethics/Law Texas BON: AI in The practitioner bears
Nursing (15.31) ultimate,
non-transferable liability
for verifying any data or
documentation
generated by ambient
AI scribes.
PART II: THE ELITE TEST BANK
Section 1: Foundational Syntax & Application
Q1: Under the 2026 Texas Board of Nursing regulations, an APRN’s prescriptive authority
agreement with a collaborating physician terminates on May 1, 2025. What is the LATEST date
the APRN is legally mandated to retain a copy of this agreement? A) May 1, 2026 B) May 1,
2027 C) December 31, 2027 D) Indefinitely, as part of the permanent professional record.
● The Answer: B (May 1, 2027)
● Distractor Analysis:
○ A is incorrect: One year is insufficient and violates Board Rule 222.5(h).
○ C is incorrect: Record retention is based on the exact anniversary date, not the
calendar year-end.
○ D is incorrect: Indefinite retention is a bureaucratic myth; the legal standard is
exactly two years.
The Mentor's Analysis: Regulatory compliance is absolute. Texas is not a full-practice
authority state; your ability to practice hinges on your collaborative paperwork. The Board
demands a two-year retention period to ensure audit trails remain intact during biennial license
renewals. Professional Intuition: Your license is your livelihood. Never discard legal
documentation before the statutory expiration.
Q2: According to the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD)
report, a patient presents with a history of a single moderate exacerbation in the past 12
months. Which category BEST classifies this patient's disease activity? A) Group A B) Group B
C) Group C D) Group E
● The Answer: D (Group E)
● Distractor Analysis:
○ A & B are incorrect: These groups represent patients with zero or one
non-hospitalized exacerbation without moderate/severe features under legacy
guidelines.
, ○ C is incorrect: Group C and D were consolidated into Group E in recent updates to
simplify exacerbation risk.
○ D is correct: The 2026 guidelines lower the threshold; a single exacerbation
meaningfully increases the probability of recurrent events, placing them in Group E.
The Mentor's Analysis: The 2026 GOLD update radically shifted risk assessment. We no
longer wait for a second exacerbation to escalate care. A single moderate exacerbation proves
the disease is biologically unstable. Professional Intuition: One strike means the patient is at
high risk for recurrence. Escalate immediately.
Q3: Under the 2026/2027 KDIGO clinical practice guidelines for Anemia in Chronic Kidney
Disease (CKD), which intervention is designated as the PREFERRED FIRST-LINE therapy? A)
Hypoxia-inducible factor prolyl hydroxylase inhibitors (HIF-PHIs) B) Routine red blood cell
transfusions C) Erythropoiesis-stimulating agents (ESAs) D) High-dose oral iron
supplementation
● The Answer: C (Erythropoiesis-stimulating agents (ESAs))
● Distractor Analysis:
○ A is incorrect: While HIF-PHIs are newly incorporated into the 2026 guidelines,
ESAs remain the preferred first-line due to established cardiovascular safety
profiles.
○ B is incorrect: Transfusions are a last resort due to alloimmunization risks,
especially in potential transplant candidates.
○ D is incorrect: Proactive IV iron, not oral, is emphasized for hemodialysis patients.
The Mentor's Analysis: Novel therapies like HIF-PHIs are exciting, but standard-of-care relies
on vast, longitudinal safety data. ESAs remain the vanguard for CKD anemia. Professional
Intuition: Do not abandon proven first-line therapies for novel agents unless specifically
indicated by patient contraindications.
Q4: The CMS Hierarchical Condition Categories (HCC) V28 model is fully implemented for the
2026 payment year. A practitioner is documenting care for a patient with diabetes. To ensure
accurate risk adjustment, the documentation must SPECIFICALLY capture which of the
following? A) The patient's exact A1C percentage from the last 30 days. B) The presence of
diabetes with explicit systemic or glycemic complications. C) A referral to a certified diabetes
educator. D) The legacy V24 code for "Diabetes without Complication."
● The Answer: B (The presence of diabetes with explicit systemic or glycemic
complications.)
● Distractor Analysis:
○ A & C are incorrect: While clinically relevant, lab values and referrals alone do not
drive HCC V28 risk capture; the specific diagnostic nomenclature does.
○ D is incorrect: V28 eliminates over 2,000 legacy codes. "Diabetes without
Complication" (HCC 19) transitions to a highly specific V28 code (HCC 38) requiring
explicit complication documentation.
The Mentor's Analysis: If it is not documented accurately under V28, the acuity of your patient
population is invisible to CMS. V28 demands hyper-granularity. Professional Intuition: Code
the whole patient. A complication changes the entire financial and clinical trajectory of the care
plan.
Q5: Per the 2026 American Diabetes Association (ADA) Standards of Care, a patient with Type
2 Diabetes is initiating a lifestyle management plan. What is the TARGET weight loss
percentage recommended to significantly alter the disease trajectory? A) 2-3% B) 5-7% C)
10-15% D) 20%
● The Answer: B (5-7%)
